Helixgate https://validator.w3.org/feed/docs/rss2.html New subpoena suggests DOJ has begun criminal investigation of gender-affirming care Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay Behind Galapagos’ transformation into Lakefront Biotherapeutics Lilly maintains weight loss leadership as Foundayo, Zepbound keep pounds off after switching After ‘most damaging period in FDA history,’ Makary will be hard to replace Tessera reveals strongest data yet for in vivo sickle cell therapy Extreme heat is worsening faster for Black Americans [Podcast] Closing the Distance in Cancer Care Merck KGaA’s clients are stockpiling due to Iran war, supporting guidance boost Gene Therapy ETX101 Improves Seizures and Neurodevelopment in Dravet Syndrome in Phase I/II STAT+: Drug meant to make gene therapy safer may also make it less effective Opinion: Access to air conditioning is critical preventive care. But federal policy treats it as optional STAT+: Bill Cassidy risked his legacy. It may not be enough to save his career Scientist as strategist: expanding the role beyond the bench Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue? Lilly, J&J CEOs top pharma’s highest paid list—again AstraZeneca pens agentic AI licensing deal with Owkin 10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit Home Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options STAT+: Why Marty Makary was the worst FDA commissioner in 25 years AAVs in Focus: Practical Approaches to Capsid Analytics and Plasmid DNA Control Males who discuss suicide seek help less often than females, report finds Acute Myeloid Leukemia Therapy Improved by CRISPR Stem Cell Transplant FDA chief Marty Makary resigns from agency, ending tumultuous tenure FDA’s Makary to resign after Secretary Kennedy signs off EU reaches provisional deal on Critical Medicines Act STAT+: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in FDA Commissioner Makary to resign, source says What I learned at a journalism fellowship about covering healthcare AI Supreme Court extends mifepristone deadline Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech Pfizer and Arvinas give disappointing breast cancer drug to Rigel STAT+: STAT examines America’s deadliest drug Bayer to make ‘careful but aggressive’ return to pharma M&A, CEO says Biotech’s IPO tide is finally turning, thanks in part to the recent M&A surge Introducing Benchling Biologics: AI infrastructure for modern drug discovery (Americas Session) Knit Health raises $11.6M for ‘fundamentally different’ approach to healthcare AI BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal STAT+: Capsida says it still doesn’t know what caused gene therapy death  BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival FDA turns to old drugs to address new diseases, persistent medical needs Scientists say this algae could remove microplastics from drinking water A year after Vertex’s big launch, pain drug research faces a pivotal moment Flagship startup, Serif, says it has solved non-viral gene therapy in monkeys STAT+: In the battle of sepsis algorithms, performance alone doesn’t predict victory Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B PCOS’s new name is PMOS, a small letter change that required a big scientific process STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs